Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.
Shen Y, Li J, Nitta M, Futalan D, Steed T, Treiber JM, Taich Z, Stevens D, Wykosky J, Chen HZ, Carter BS, Becher OJ, Kennedy R, Esashi F, Sarkaria JN, Furnari FB, Cavenee WK, Desai A, Chen CC.
Shen Y, et al. Among authors: chen cc, chen hz.
Oncotarget. 2015 May 20;6(14):11751-67. doi: 10.18632/oncotarget.3996.
Oncotarget. 2015.
PMID: 26059434
Free PMC article.